LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/Fractures Hotbed of Infection? Yes! New Study From Sweden
Large Joints and Extremities

Fractures Hotbed of Infection? Yes! New Study From Sweden

June 13, 2014 2 min read Premium comments

Advertisement

Fractures Hotbed of Infection? Yes! New Study From Sweden
Hip fracture/Wikimedia Commons and booyabazooka
Secondary

Surgical site infections (SSI) occur in 0.7% of knee replacement surgeries and in 1% of hip replacements. SSI’s are the most common cause for rejection of the prostheses in hip replacement surgery, according to a number of studies presented in London at a conference of the European Center for Disease Prevention and Control (ECDC).

A Swedish study, presented at the conference, found that fracture patients who get an artificial hip have a significantly higher risk of infection than do people who undergo similar surgery due to a degenerative hip disease. Investigators found that joint infections occurred most often in cases with secondary fracture prosthesis. This was about 2.8% of cases—including cases where internal fixation had failed. Younger patients were at higher risk of infection than were older people.

The Swedish study revealed how difficult the treatment of postoperative infections can be. Only 40% of the cases could be cured. In 42% of the cases doctors brought the structural infection under control only after permanent resection arthroplasty. Almost all of these cases were fracture patients. Ten percent of the patients required a life-long antibiotic therapy and 8% died during their treatment.

“Adequate prophylactic measures are necessary, especially against staphylococcus aureus and coagulase negative staphylococci, the most decisive factors in infection among fracture patients, ” said the study’s main author, Piotr Kasina, M.D., from the Karolinska Institute, Stockholm. His research group examined the records of 3, 807 cases of hip replacement cases at the Stockholm South General Hospital between 1996 and 2005.

Researchers noted that the diagnosis of periprosthetic joint infections, and not just the treatment, presented challenges to orthopedic surgeons. An Austrian research team identified a new parameter for the detection of periprosthetic joint infections in revision arthroplasty. “We have compared the sensitivity and specificity of conventionally used biomarkers such as C- reactive protein [CRP] and leukocyte levels to that of PCT, IL-6 and interferon alpha. CRP has proven itself indeed as the best biomarker for diagnosing infections from periprosthetic revision surgery, but PCT and IL-6 were likewise shown to be helpful. They could be used as additional indicators when a diagnosis is not clearly conclusive, ” said Mathias Glehr, Ph.D., from the Graz University Hospital.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy